CJC-1295 + Ipamorelin
Growth-hormone-axis research blend — CJC-1295 (without DAC) 5 mg + Ipamorelin 5 mg in a single vial.
Overview
This blend pairs CJC-1295 (without DAC), a growth-hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth-hormone secretagogue, in a single lyophilized vial.
The two are frequently studied together because they act on complementary pathways of the growth-hormone axis in research models.
Mechanism of interest
- CJC-1295 (without DAC) — a GHRH analog studied for stimulating growth-hormone release from the pituitary in research models.
- Ipamorelin — a selective ghrelin-receptor agonist (GHRP) investigated for pulsatile GH release with minimal effect on cortisol and prolactin in studies.
- Complementary axes — the GHRH + GHRP combination is studied for additive effects on the GH/IGF-1 research axis.
Research areas
Handling & storage
- Lyophilized powder. Store sealed vials at -20°C.
- Reconstitute with bacteriostatic water; refrigerate at 2–8°C after reconstitution.
- Avoid repeated freeze/thaw cycles and protect from light.
Certificates of Analysis
Batch-specific purity, independently verified by HPLC.
| Lot | Purity | Method | Date | COA |
|---|---|---|---|---|
251215-LUL-CP10-01 Vanguard Laboratory (ISO 17025) | 99.32% | HPLC-UV/VIS | 2026-02 | Download ↓ |
Selected references
- 1.Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting GHRH analog. J Clin Endocrinol Metab. 2006.
- 2.Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
Order
Buy direct from Regenix.
Pricing & direct checkout launching soon — add to cart to save your selection.
Want it now? Buy direct
We'll refer you to one of our preferred providers — they complete your medical qualification and submit it to a licensed physician.
Request direct purchase →All products are sold for laboratory and research use only. Not for human consumption, diagnosis, treatment, or cure of any condition. Not evaluated by the FDA.